Numerous clinical studies are investigating the therapeutic potential of IL-2 in autoimmune diseases and focus on the expansion of Tregs (20–23); however, it is not known whether the therapeutic efficacy of IL-2 is solely attributable to the expansion of Tregs. Here, IL2 is linked to autoimmune disease.